Zealand Pharma A/S (ZLDPF)
33.08
0.00 (0.00%)
USD |
OTCM |
Oct 27, 16:00
Zealand Pharma Price to Book Value : 0.8389 for Oct. 27, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 27, 2026 | 0.8389 |
| October 26, 2026 | 0.8389 |
| October 23, 2026 | 0.8591 |
| October 22, 2026 | 0.8749 |
| October 21, 2026 | 0.8749 |
| October 20, 2026 | 0.8617 |
| October 19, 2026 | 0.8467 |
| October 16, 2026 | 0.8622 |
| October 15, 2026 | 0.8622 |
| October 14, 2026 | 0.8662 |
| October 13, 2026 | 0.8841 |
| October 12, 2026 | 0.8841 |
| October 09, 2026 | 0.9039 |
| October 08, 2026 | 0.9519 |
| October 07, 2026 | 0.9519 |
| October 06, 2026 | 0.9667 |
| October 05, 2026 | 1.014 |
| October 02, 2026 | 1.014 |
| October 01, 2026 | 0.9661 |
| September 30, 2026 | 1.107 |
| September 29, 2026 | 1.065 |
| September 28, 2026 | 1.065 |
| September 25, 2026 | 1.065 |
| September 24, 2026 | 1.065 |
| September 23, 2026 | 1.093 |
| Date | Value |
|---|---|
| September 22, 2026 | 1.093 |
| September 21, 2026 | 1.090 |
| September 18, 2026 | 1.090 |
| September 17, 2026 | 1.090 |
| September 16, 2026 | 1.090 |
| September 15, 2026 | 1.090 |
| September 14, 2026 | 1.090 |
| September 11, 2026 | 1.176 |
| September 10, 2026 | 1.176 |
| September 09, 2026 | 1.176 |
| September 08, 2026 | 1.176 |
| September 04, 2026 | 1.208 |
| September 03, 2026 | 1.208 |
| September 02, 2026 | 1.199 |
| September 01, 2026 | 1.199 |
| August 31, 2026 | 1.181 |
| August 28, 2026 | 1.250 |
| August 27, 2026 | 1.250 |
| August 26, 2026 | 1.314 |
| August 25, 2026 | 1.314 |
| August 24, 2026 | 1.223 |
| August 21, 2026 | 1.281 |
| August 20, 2026 | 1.268 |
| August 19, 2026 | 1.268 |
| August 18, 2026 | 1.244 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Genmab A/S | 5.748 |
| Ascendis Pharma A/S | 9.982 |
| Bavarian Nordic A/S | 1.434 |
| Evaxion AS | 2.721 |
| ACADIA Pharmaceuticals, Inc. | 2.675 |
Price to Book Value Related Metrics
| PE Ratio | 5.514 |
| PS Ratio | 3.231 |
| Price | 33.08 |
| Earnings Yield | 18.13% |
| Market Cap | 2.309B |
| Operating PE Ratio | 6.411 |
| Normalized PE Ratio | 5.471 |